| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |